Unihealth Hospitals Ltd
Incorporated in 2010, Unihealth Consultancy Ltd is in the business of Medical Tour Operator and Health Consultancy Service & Trader in Medical Equipments[1]
- Market Cap ₹ 277 Cr.
- Current Price ₹ 180
- High / Low ₹ 191 / 109
- Stock P/E 18.3
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE 17.2 %
- ROE 16.0 %
- Face Value ₹ 10.0
Pros
- Company has delivered good profit growth of 75.9% CAGR over last 5 years
Cons
- Company has high debtors of 328 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Half Yearly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
22 | 26 | 37 | 44 | 49 | 56 | |
20 | 20 | 25 | 30 | 31 | 37 | |
Operating Profit | 2 | 7 | 12 | 14 | 18 | 18 |
OPM % | 10% | 25% | 31% | 31% | 36% | 33% |
1 | 2 | 1 | 2 | 2 | 3 | |
Interest | 2 | 1 | 5 | 4 | 3 | 2 |
Depreciation | 2 | 2 | 2 | 3 | 2 | 2 |
Profit before tax | -1 | 5 | 5 | 9 | 14 | 17 |
Tax % | 2% | 9% | 27% | 17% | 24% | 12% |
-1 | 5 | 4 | 8 | 10 | 15 | |
EPS in Rs | ||||||
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 20% |
3 Years: | 15% |
TTM: | 14% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 76% |
3 Years: | 60% |
TTM: | 47% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | 46% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 22% |
3 Years: | 19% |
Last Year: | 16% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
Equity Capital | 1 | 1 | 1 | 1 | 15 | 15 |
Reserves | 4 | 9 | 13 | 26 | 70 | 88 |
41 | 39 | 38 | 39 | 15 | 13 | |
12 | 9 | 12 | 12 | 10 | 16 | |
Total Liabilities | 58 | 58 | 65 | 78 | 110 | 132 |
35 | 35 | 36 | 37 | 36 | 40 | |
CWIP | 2 | 0 | 0 | 0 | 0 | 5 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 |
20 | 22 | 28 | 41 | 74 | 87 | |
Total Assets | 58 | 58 | 65 | 78 | 110 | 132 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
1 | 4 | 9 | 1 | 5 | -3 | |
-1 | 0 | -3 | -5 | 0 | -4 | |
1 | -3 | -6 | 3 | 22 | -3 | |
Net Cash Flow | 0 | 1 | 0 | -0 | 27 | -10 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
Debtor Days | 206 | 198 | 180 | 228 | 251 | 328 |
Inventory Days | 50 | 86 | 78 | 98 | 88 | 64 |
Days Payable | 382 | 91 | 79 | 137 | 104 | 86 |
Cash Conversion Cycle | -125 | 192 | 180 | 188 | 235 | 306 |
Working Capital Days | 114 | 162 | 146 | 170 | 228 | 322 |
ROCE % | 14% | 20% | 22% | 20% | 17% |
Documents
Announcements
-
Updates
4 June 2025 - Unihealth submits statutory auditor certificate on IPO fund use and approved reallocation of Rs.1350 lakhs to subsidiaries.
-
Analysts/Institutional Investor Meet/Con. Call Updates
30 May 2025 - UniHealth reports FY25 revenue ₹58.41 Cr, net profit ₹15.14 Cr; plans 1000+ beds expansion in India and Africa.
-
Structural Digital Database
27 May 2025 - UniHealth submits SDD compliance certificate for FY 2024-25 with no non-compliances reported.
-
Analysts/Institutional Investor Meet/Con. Call Updates
26 May 2025 - Audio recording of UniHealth's FY25 earnings call available on company website.
-
Investor Presentation
26 May 2025 - Unihealth reports H2 FY25 revenue growth, new hospital launches in India and Africa, and Uganda's first advanced IVF facility.
Annual reports
Concalls
-
May 2025Transcript PPT
-
Nov 2024Transcript PPT REC
-
May 2024Transcript PPT
-
Nov 2023Transcript PPT
Business Overview:[1]
a) UHCL is an ISO 9001:2015 certified healthcare service provider with a global presence, especially in Africa.
b) The company operates medical centers and hospitals, provides consultancy services, distributes pharmaceutical and medical consumable products, and offers medical value travel.
c) UHCL is involved in healthcare consultancy projects in India and various African countries, and exports and distributes pharma and medical consumable products to Uganda, Tanzania, and Nigeria.
d) It acts as a distributor for several Indian manufacturers in these African nations.
e) The company has 4 centers and 2 hospitals, with over 150 doctors and specialists treating more than 1.10 lakh patients annually.
f) UHCL manages two multi-specialty facilities with a total of 200 operational beds and has over 1,200 beds in projects under consultancy.